The unmethylated CpG DNA can prevent spontaneous apoptosis of B cells. However, the precise mechanisms by which CpG DNA blocks apoptosis remain unclear. In this study, we showed B cell apoptosis was significantly 
Introduction
The unmethylated CpG DNA, also termed immunostimulatory DNA sequences (ISS), can activate a set of immune cell responses (1) . CpG DNA stimulates immune cells to produce cytokines, and promotes cell proliferation, CpG DNA has also been identified to protect cell from apoptosis (2, 3) . Apoptosis plays an essential role in the development and tissue homeostasis (4, 5) as well as disease treatment (6, 7) . The apoptosis process is controlled by a series of caspases which are regulated through several steps by different mechanisms including changes in mitochondrial membrane permeability and subsequent release of proapoptotic factors such as cytochrome c (cyto c), apoptotic inducing factor (AIF), and second mitochondria derived activator of caspase (Smac). Cytosolic cyto c and Apaf1 form an important complex which leads to activation of caspases. The cell apoptosis processing is regulated by the inhibition of caspases activation through Bcl family members, inhibitor of apoptosis (IAP) and calpain (8, 9) .
The phosphoinositide 3'-OH kinase (PI3K) and its downstream AKT kinase have been implicated in the control of major cellular responses including cell proliferation, survival, development, differentiation, cell cycle, and apoptosis (10, 11) . Upon activation by growth factor, the membrance receptor tyrosine kinases recruit and activate PI3K which converts phosphoinositides [PI (4, 5 )P2] to [PI (3, 4, 5) P3] which in turn recruits protein kinase B (PKB/AKT) where AKT is phosphorylated by PDK1 and PDK2 (12, 13) . The phosphorylation of PKR/AKT results in full activation of AKT kinase activity and function.
It has been reported that PKB/AKT inhibits apoptosis. In growth cells, activated AKT phosphorylates BAD which prevents its binding with Bcl-xL (14) . AKT can also phosphorylate caspase 9 and abrogate its pro-apoptotic function (15) . A study suggested that the PI3K/AKT signal pathway was involved in CpG inhibition of apoptosis in dendritic cell (DC) (2) . However, the mechanism for how CpG DNA inhibits apoptosis is not yet completely understood.
In this study, by using bone morrow-derived macrophages (BMDMs) and splenic B lymphocytes, we found evidence for a more general mechanism. CpG DNA can up-regulate Bcl-xL and IAP; CpG DNA can activate PI3K/AKT kinase activity, and consequently down-regulate active caspase 3 and p53, and stimulate phosphorylation of Rb, adding complexity to the mechanisms of CpG DNA inhibitions of apoptosis.
Materials and Methods
Mice C57BL/6J mice (1-2 month old) were purchased from Shanghai experimental animal center. All mouse strains were maintained under specific pathogen-free conditions in the experimental animal center of Tongji University.
Reagents and Abs
Phosphorothioate oligodeoxynucleotides (ODNs) were purchased from Trilink. Less than 0.01 U/g of endotoxin was presented in any of ODNs used here. LPS was obtained from Sigma. Anti-mouse p53, Bcl-xL, cIAP, phosphorylation Rb (S780), AKT1, AKT2 and AKT3 Abs were purchased from Santa Cruz Biotechnology. Mouse anti-gamma tubulin was from Sigma. The PI3K inhibitors, wortmanin and Ly294002 (Ly) were from Calbiochem and dissolved in DMSO.
Cell culture
The cells were cultured in a 5% CO 2 incubator at 37 o C. BMDMs were routinely cultured in 20% L cell condition media as previously established method (16) . Splenic B lymphocytes were cultured in RPMI 1640 supplemented with 10% FCS, 1 mM sodium pyruvate, 0.1 mM essential amino acid and 60 M 2-mercaptoethanol.
Splenic B cell isolation and purification
Splenic B cells were isolated and purified following the instructions of B220 kit (Miltenyi Biotec Inc., Cat# 130-049-501). The single B cell suspension was torn from spleen, and then labeled with CD45R (B220) microbeads for 15 min on ice. Cells were washed by addition 10× volume of degas buffer and allowed to run through the column. Then the column was washed 3 times with buffer and removed from magnetic field and the B220 positive cell suspension was collected.
Caspase activity assay and flow cytometry (FCM) Splenic B cell apoptosis was determined by CaspaTag Flurescein Caspase Activity Kit (Serological Inc., Cat# S7300-100). Briefly, cells were incubated with carboxyfluorescein labeled fluormetyl ketone peptide for 1 h, and washed 3 times with washing buffer. Then the samples were fixed and further analyzed with FCM.
DNA extraction and electrophoresis
Purified splenic B cell DNA samples were lysated in 0.5 ml lysis buffer (10 mM Tris, pH 8.0, 100 mM EDTA and 1% SDS, pH 7.8) with 0.2 mg/ml proteinase K at 50 o C overnight, followed by extraction with phenol/chloroform/isoamyl alcohol. The isopropanol precipitated DNA were resuspended in TE with 50 mg/ml RNase A. DNA were subjected to electrophoresis in a 4% agarose gel.
Kinase assay and immunobloting (IB)
AKT kinase assays and immunoblotting were performed according to Li et al. (17) . Briefly, cell lystaes were incubated with appropriate antibody and 20 l of protein A/G agarose beads at 4 o C overnight. The beads were washed 3 times with appropriate washing buffer. Immunoprecipitated cell lysates were then incubated with GST-GSK3 substrate and 32 P-ATP at 30 o C for 30 min. Reaction was stopped by adding equal volume of 2× sample buffer and then boiled for 2 min. The samples were separated on 12.5% SDS-PAGE gel and transferred into a PVDF membrane visualized by autoradiography. For IB assay, the membranes were blotted with the appropriate antibody and visualized with ECL.
Western blot analysis
Purified splenic B cells were cultured with CpG DNA (10 g/ml) or LPS (10 g/ml) and harvested at indicated time points. A total of 40 g of cell extracts from each sample was loaded on a 12.5% SDS-PAGE and transferred onto PVDF membranes. After blocking of membrane in 5% non-fat milk, the blots were probed with specific Abs and visualized with the appropriate HRP-conjugated secondary Abs (Santa Cruz) and an ECL detection system (Pierce Rockford).
Statistical analysis
Variables are reported as the mean ± standard deviation (SD) of more than three separate experiments performed in triplicate. Statistical analysis between two groups was performed with two-tailed t tests, p-values less than 0.05 were considered to be significant.
Results
Inhibition of spontaneous B cell apoptosis by CpG DNA was correlated to up-regulation of Bcl-xL, IAP and down-regulation of p53 and caspase 3 We showed, through the detection of activated caspases with FCM, that primary B cells in normal culture condition underwent spontaneous apoptosis, which is consistent with previous works (18, 19) . About 47.48 ± 3.30% of splenic B lymphocytes underwent spontaneous apoptosis that could be inhibited by the addition of LPS (16.58 ± 1.53%, p < 0.005) as a positive control. B cell apoptosis was also significantly inhibited by adding CpG DNA (9.69 ± 1.62%, p < 0.005), instead of GpC DNA (45.90 ± 2.00%, p > 0.05) ( Figure 1A) . B cell DNA was extracted and subjected to 4% agarose gel electrophoresis to verify CpG DNA's character to rescue B cells from apoptosis. As shown in Figure 1B , spontaneous apoptotic B cell showed DNA ladders, the characteristic feature of apoptosis, in 24 h culture (Lane 3) that could be Volume 6 Number 3 June 2009 blocked by either CpG DNA (Lane 4) or LPS (Lane 6) treatment. It has been known that apoptosis is triggered by activation of caspases, such as caspase 3, which are regulated by Bcl-2 family members and IAPs, as well as p53 (9) . We thus examined the apoptosis related protein levels in above samples by Western blots. As shown in Figure 2 , consistent with above FCM data, the expression of caspase 3 was induced at 24 h compared with the basal expression level (time 0). However, treatment with either CpG DNA or LPS dramatically reduced caspase 3 level. Whereas, the IAP and Bcl-xL, those were both known as important apoptosis inhibitory proteins, were decreased in untreated cells at 24 h. But with CpG DNA or LPS treatment, their protein levels significantly increased. Tumor suppressor gene product p53 plays an important role in cell cycle and cell death (20) . However, little is known about its role in CpG signaling. The results showed that CpG DNA could inhibit p53 protein expression whose level was increased in B cell spontaneous apoptosis at 24 h.
PI3K/AKT was involved in CpG DNA inhibition of spontaneous B cell apoptosis
It was reported that PI3K and its downstream products were involved in the survival of many cell types. Also, the PI3K inhibitor, wortmannin, could inhibit CpG DNA induced cytokine production (21, 22) . Accordingly, we also addressed whether the activation of PI3K/AKT was involved in CpG DNA-inhibition of B cell apoptosis. As shown in Table 1 AKT was activated by CpG DNA With survival signaling, PI3K is activated, leading to PKB/AKT phosphorylation which is required for the + B cells were treated with CpG DNA (5 g/ml), GpC DNA (5 g/ml), LPS (10 g/ml) or left untreated for 24 h (Med), and then whole cell lysates were subjected into 12.5% SDS-PAGE, and transferred onto PVDF membrane. After blocking with 5% non-fat milk, the membrane was then probed with the primary antibodies as indicated and then visualized with HRP-conjugated secondary Abs and an ECL system. The caspase 3 and p53 protein levels were down-regulated, and IAP and Bcl-xL protein levels were up-regulated by CpG DNA. B220 + B cells responded LPS treatment in the patterns as expected. activation of AKT kinase activity and the subsequent regulation of a varity of protein substrates that affect cell growth, cell cycle and cell survival including BAD, IB kinase, procaspases-9, p21, GSK-3a/b, FKHR, etc. (13) . Previous study reported that AKT kinase was activated and phosphorylated by DNA-PKc in the presence of CpG DNA in vitro (23) . We harvested BMDMs after the treatment of CpG DNA or LPS as a control following serum free medium 3 h. These samples were used to test the AKT kinase activity. As shown in Figure 3 , the AKT 1, AKT 2 and AKT 3 kinase activities in macrophages were increased considerably with the incubation of CpG DNA from 15 min to 2 h. p53 was down-regulated by CpG DNA via PI3K/AKT pathway, but not Bcl-xL or IAP It has been reported that CpG DNA up-regulated Bcl-xL and IAP through PI3K pathway in DC (2) . However, as shown in Figure 4 , treatment with Ly294002 at 25 M could not inhibit Bcl-xL and IAP expression induced by CpG DNA even at 48 h. These data suggested that Bcl-xL and IAP up-regulation by CpG DNA were mostly not mediated through PI3K/AKT pathway but other pathways. p53 is a protein of many important talents, including cell cycle arrest and tumor suppressor. p53 plays a role in triggering apoptosis under certain conditions (24) . It has been reported that p53 mediated apoptosis could be delayed by activated PI3K/AKT (25) . Thus the hypothesis whether p53 is involved in CpG DNA inhibiting apoptosis through PI3K/AKT pathway is tested here. As shown in Figure 4 , p53 protein level was increased in spontaneous apoptotic B cell at 48 h, and CpG DNA treatment decreased p53 protein level. Treatment with Ly294002 could increase p53 protein level even in the presence of CpG DNA. Since p53 can inhibit Rb phosphorylation which is associated with cell proliferation. In consistence with this model, CpG DNA could induce phosphorylation of Rb that could also be blocked by treatment of Ly294002 (Figure 4 ). These data highly suggested that p53 played an important role in CpG DNA inhibition of B cell apoptosis and that p53 was down-regulated by CpG DNA via PI3K/AKT pathway.
Discussion
Unmethylated CpG DNA can stimulate murine and human lymphocytes. CpG DNA directly stimulates B cells, macrophages, and dendritic cells to secrete cytokines, express costimulatory molecules and show increased antigenpresentaion (1, 26) . CpG DNA also promotes cell proliferation for B lymphocytes, macrophages, and NK cells in mice. CpG DNA has been shown to prevent spontaneous apoptosis in B cells (19) and dendritic cells (2) and anti-IgM induced apoptosis (1) . Identification of the mechanisms of apoptosis and its regulations has laid a foundation for the discovery of drugs and disease treatment (27, 28) . CpG DNA has been implicated in treatment applications for diseases such as asthma and cancer (1, 29) . A fully elucidation of the mechanisms of CpG DNA inhibition of apoptosis makes the CpG DNA based treatment efficient and safe.
The p38 MAPK pathway is activated by CpG DNA, and is crucial for CpG DNA-induced cytokine production. However, it has been reported that p38 MAPK pathway is not involved in the anti-apoptotic activity of CpG DNA (2). PI3K and its downstream AKT have been shown to play an important role in promoting cell survival (10, 30) . CpG DNA/ODN can activate PI3K to regulate a variety of cellular responses (31, 32) . AKT has been shown to inhibit cell apoptosis in Rat1a fibroblasts in proportion to its kinase activity (33) , and it has been reported that CpG DNA inhibits DC (2) and macrophage (34) apoptosis in a PI3K dependent manner. In this study we showed proof of that the PI3K/AKT was involved in the CpG DNA inhibition of B cell apoptosis (Table 1) . PI3K inhibitor wortmannin could abrogate the protection of B cell from apoptosis by CpG DNA, which was in a wortmannin dose dependent manner. CpG DNA could activate AKT kinase activity. It was reported that AKT could phosphorylate Bad, resulting in Bad's dissociation from Bcl-2/Bcl-xL, and formation of a complex with 14-3-3 protein in which Bad was unable to promote apoptosis. However, this mechanism cannot be applied universally because Bad is not expressed in all cell types (35) and Bad phosphorylation can be mediated via an AKT independent pathway (2). It has been reported that CpG DNA-mediated DC survival is still sustained when the expressions of Bcl-2 and Bcl-xL are significantly reduced. These data let us hypothesize that other key PI3K/AKT downstream player rather than Bcl-2 and Bcl-xL is involved in CpG DNA inhibition of apoptosis. As shown in Figure 4 , another PI3K inhibitor, Ly294002 (25 M) could not abrogate the induction of Bcl-xL and IAP, and other observations demonstrated that activated AKT did not alter Bcl-xL expression but inhibited caspase activity (25, 33) .
Recently Kou reported that CpG-B ODN increased expression of Bcl-xL by stress-inducible Hsp70 via a TLR9/MyD88/PI3K signaling pathway (34) , which further confirmed our observation that up-regulation of Bcl-xL and IAP by CpG DNA was mostly not mediated through PI3K/AKT pathway.
CpG DNA also can induce AKT 1, 2, 3 kinase activities in BMDMs in mice. It has also been reported that AKT inhibits apoptosis by preventing the release of cytochrome c from mitochondria (36) , and both constitutively active PI3K and AKT delay the onset of p53-mediated apoptosis (25) . Activation of AKT kinase was found to inhibit p53-induced neuronal death (37) . AKT can phosphorylate MDM2, and phosphorylation of MDM2 is associated with nuclear localization of MDM2, and enhance degradation of p53 (38, 39) . Therefore we hypothesize that p53 may also play an important role in CpG DNA inhibition of B cell apoptosis through PI3K/AKT pathway. Our data showed that p53 was mediated by CpG DNA inhibition of B cell apoptosis in PI3K/AKT pathway. First, p53 protein level was increased in spontaneous apoptosis B cells and CpG DNA treatment decreased p53 level. Second, CpG DNA inhibition of p53 level was associated with increased phosphorylation of Rb that was required for cell proliferation and regulated by p53. Third, treatment with Ly294002 could increase p53 protein level and decreased phosphorylation of Rb in the presence of CpG DNA. Taken together, these results suggest that p53 plays an important role in CpG DNA inhibition of B cell apoptosis and that p53 is down-regulated by CpG DNA via PI3K/AKT pathway. To our understanding we here first time showed that CpG DNA could inhibit p53 protein expression whose level was increased in B cell spontaneous apoptosis.
Taken together, we have proposed that CpG DNA inhibits spontaneous B cell apoptosis where PI3K/AKT plays impotant role by down-regulation p53 and active caspase 3. CpG-ODN up-regulation Bcl-xL and IAP also inhibits spontaneous B cell apoptosis which is most likely not mediated through PI3K/AKT pathway but other pathways. + B cell were treated with CpG DNA (5 g/ml), GpC DNA (5 g/ml), LPS (10 g/ml) or left untreated for 48 h in the presence of PI3K inhibitor LY294002 (25 M) or not. Cell lysates were collected and subjected into 12.5% SDS-PAGE, and transferred onto PVDF membrane. After blocking with 5% non-fat milk, the membrane was then probed with the primary antibodies as indicated and then visualized with HRP-conjugated secondary Abs and an ECL system.
